Successful amelioration of hemophilia A has been reported by several groups targeting the liver-expressed mouse Alb locus in vivo using AAV vectors to transfer the transgene into the liver (Sharma et al., 2015; Chen et al., 2019; Zhang et al., 2019). This evidence concerns the gene ALB and hemophilia A.